How do chromaffin cell secretory stimuli program resynthesis of secreted peptides and amines? We previously showed that the physiologic nicotinic cholinergic signal for secretion also activates the biosynthesis of chromogranin A, the major protein released with catecholamines. Here, we examine signal transduction pathways whereby secretory stimuli influence exocytotic secretion versus chromogranin A transcription. Both secretion and transcription depended on initial nicotinic-triggered sodium entry into the cytosol, followed by calcium entry through L -type voltage-gated channels. When calcium entered through L -type channels, activation of secretion paralleled activation of transcription ( r ϭ 0.897, P ϭ 0.002). Calcium entry from intracellular stores or through calcium ionophore channels activated secretion, though not transcription. Nicotinic-stimulated transcription depended upon protein kinase C activation; nicotine caused translocation of protein kinase C to the cell membrane fraction, and inhibition of protein kinase C blocked activation of transcription, while activation of protein kinase C mimicked nicotine effects. Transcriptional responses to both nicotine and protein kinase C mapped principally onto the chromogranin A promoter's cAMP response element (TGACGTAA; CRE box). KCREB, a dominant negative mutant of the CREbinding protein CREB, blunted activation of chromogranin A transcription by nicotine, phorbol ester, or membrane depolarization. We conclude that activation of chromogranin A transcription by secretory stimulation in chromaffin cells is highly dependent upon precise route of calcium entry into the cytosol; transcription occurred after entry of calcium through L -type channels on the cell surface, and was mediated by protein kinase C activation. The trans -acting factor CREB ultimately relays the secretory signal to the chromogranin A promoter's CRE box in cis. ( J. Clin. Invest.
Introduction
During trans -synaptic induction, the response of postsynaptic cells to incoming synaptic signals includes activation of a variety of gene programs, both acute and long-term (1) .
When chromaffin cells and sympathetic axons release by exocytosis their complement of cosecreted catecholamines and peptides (2) , mechanisms are activated to replenish secretory vesicles with the just-secreted components. The rate-limiting enzyme in catecholamine synthesis, tyrosine hydroxylase (3, 4) , is transcriptionally activated by the physiologic nicotinic cholinergic signal to chromaffin cell exocytosis. Induction of tyrosine hydroxylase by chromaffin cell secretory stimuli may require the cAMP response element in the tyrosine hydroxylase promoter, as well as protein kinase A activity in the cell (3, 4) . Other catecholamine biosynthetic enzymes, such as phenylethanolamine-N -methyltransferase and dopamine ␤ -hydroxylase, also respond to secretory stimuli (5, 6) .
The biosynthesis of secreted peptides, such as proenkephalin A (7) and neuropeptide Y (8) , is likewise activated by nicotinic stimulation. Chromogranin A is the quantitatively major protein stored and released with catecholamines (2) . It is a prohormone, giving rise by proteolytic cleavage to several biologically active peptides (9) . We have shown (10) that chromogranin A biosynthesis is activated by nicotinic cholinergic stimulation, that the activation occurs at a transcriptional level, and that discrete chromogranin A promoter domains, including the cAMP response element (CRE box), 1 are involved in the nicotinic response. In those studies, the cAMP response element seemed to be, at least in part, both necessary and sufficient to confer nicotinic induction onto the chromogranin A promoter (10) , and nicotinic stimulation resulted in formation of the transcriptionally activated form of the cAMP response element binding protein CREB, phosphorylated at crucial serine residue 133 (10) .
Here we examine and contrast signal transduction pathways whereby nicotinic cholinergic stimulation activates catecholamine secretion versus chromogranin A transcription in chromaffin cells. Our results suggest that calcium entry into the cytosol through voltage-gated channels is a necessary intermediary in both responses, but that different calcium-dependent protein kinases are involved in triggering secretion versus transcription; protein kinase A apparently plays no role in these processes. Protein kinase C (PKC) activation seems to be rate-limiting for the transcriptional response; dominant negative (inhibitory) mutant studies with the cAMP binding protein CREB suggest that its activation signals transcription through the chromogranin A promoter's proximal cAMP response element. Only entry of calcium into the cytosol from an extracellular source is capable of activating both secretion and transcription; calcium from intracellular stores activates secretion alone. 3 H] l -norepinephrine was accomplished as previously described (22) .
To observe catecholamine secretion in the absence of extracellular calcium, [ 3 H] l -norepinephrine-labeled cells were washed twicewith calcium-free secretion buffer (152 mM NaCl, 5 mM KCl, 10 mM Hepes, pH 7.4, and 0.1 mM EGTA), and incubated in this buffer for 90 min. After twice washing again with the same buffer, the cells were incubated in the secretion buffer with or without nicotine.
When protein kinase inhibitors were used in [ 3 H-] l -norepinephrine secretion studies, these inhibitors were added 90 min before study, and maintained in the medium during the 30-min secretory stimulation period.
Pharmacology. The effect of the following agents on chromogranin A transcription and catecholamine secretion was tested at concentrations indicated in a particular experiment's results. Nicotine, EGTA, caffeine, ionomycin, nifedipine, verapamil, BaCl 2 , dibutyryl cAMP, ATP, and PMA were obtained from Sigma Chemical Company (St. Louis, MO). A23187, ryanodine, BayK-8644, KT-5720, KT-5823, KN-62, SQ-22,536, and MDL-12,330A were obtained from Calbiochem Corp., (La Jolla, CA). The protein kinase inhibitor chelerythrine was from LC Services Corporation (Woburn, MA).
To deplete PKC, in some experiments cells were pretreated with PMA (10 Ϫ 7 M) for 48 h before transfection or secretion studies. PMA (10 Ϫ 7 M) was then continued during the 48-h posttransfection period before reporter harvest.
To cause influx of extracellular calcium through l -type voltagegated cell surface calcium channels independent of nicotinic receptor activation, the following cell membrane-depolarizing (high potassium) medium was added to cells 16 h after transfection, followed by incubation in the same medium for an additional 12 h before cell harvest for reporter assay (100 mM NaCl, 55 mM KCl, 2 mM CaCl 2 , 10 mM Hepes, pH 7.4, 0.45% glucose, 100 U/ml penicillin, 100 g/ml streptomycin sulfate, 10% horse serum, and 5% fetal bovine serum). In some of these experiments, the calcium channel agonist BayK8644 was added.
In some experiments, the secretagogue barium (2 mM BaCl 2 , in barium medium: 148 mM NaCl, 5 mM KCl, 0 mM CaCl 2 , 10 mM Hepes, pH 7.4, 0.45% glucose, 1% penicillin/streptomycin, 10% horse serum, and 5% FBS) was added to cells 16 h after the transfection, followed by incubation in the same medium for an additional 24 h before harvest.
Some experiments tested the requirement of extracellular sodium for nicotinic cholinergic-stimulated catecholamine secretion, or for chromogranin A transcription. For secretion, the medium without extracellular sodium was as follows: 150 mM N -methyl-d -glucamine, 2.5 mM KCl, 2 mM CaCl 2 , and 2.5 mM K-Hepes, pH 7.4. For transcription, the cell culture medium without extracellular sodium was as follows: the above medium plus 4,500 mg/liter glucose, 100 U/ml penicillin, 100 g/ml streptomycin sulfate, 10% dialyzed heat-inactivated horse serum, and 5% dialyzed heat-inactivated FBS. Sodium-containing medium for transcription was DMEM (110 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 43 mM NaHCO 3 , pH 7.4), supplemented with 100 U/ml penicillin, 100 g/ml streptomycin sulfate, 10% heat-inactivated horse serum, and 5% heat-inactivated FBS. For sodium dependence of nicotinic-stimulated transcription, cells were first incubated in medium with sodium (without nicotine) for 2 h after transfection. Cells were then switched to medium with or without sodium (see above), and with or without nicotine (10 Ϫ 3 M), for 12 h. The medium on all cells was then changed to sodium-containing, without nicotine, for another 10 h. For sodium-dependence of PMA-stimulated transcription, cells were first incubated in medium with sodium (without PMA) for 12 h after transfection. Cells were then switched to medium with or without sodium (see above), and with or without PMA (0.1 M), for 6 h. The medium on all cells was then changed to sodiumcontaining, without PMA, for another 6 h. At the end of the stimulation periods (24 h after transfection), cells were harvested for assay of luciferase and protein.
To create a medium free of extracellular calcium in some transcription experiments, cells were washed three times with calcium-free medium (152 mM NaCl, 5 mM KCl, 10 mM Hepes, pH 7.4, 0.1 mM EGTA, 0.45% glucose, 100 U/ml penicillin, 100 g/ml streptomycin sulfate, 10% dialyzed heat-inactivated horse serum, and 5% dialyzed heat-inactivated FBS) 16 h after transfection, at which time nicotine (or mock secretagogue) was added. After 8 h of further culture in this medium with or without nicotine, cells were harvested.
Cytosolic calcium responses of PC12 cells to secretagogues were observed using fluorescence of the calcium-binding dye Fura-2 (23). Cells were preloaded for 20-30 min with Fura-2/AM (acetoxymethylester; Molecular Probes Inc., Eugene, OR), washed twice, and fluorescence was visualized in a fluorometer (Perkin Elmer Corp., Norwalk, CT) with wavelengths of 340 and 380 nm for excitation, and 510 nm for emission.
Secretagogue-activated radiolabeled cation (Ca 2 ϩ or Na ϩ ) fluxes from the extracellular space into PC12 cells were measured over 5 min as previously described (24, 25) . After 12 h of nicotinic (10 Ϫ 3 M nicotine, versus mock) stimulation, PC12 cells from 10-cm plates were harvested with 0.5 ml PBS (140 mM NaCl, 5 mM KCl, and 15 mM Na-phosphate pH 7.4) and lysed by sonication (40% power, five pulses, 5 s/pulse). Lysed cells were centrifuged at 100,000 g for 60 min. To remove endogenous phospholipid activators, the ‫ف‬ 0.5 ml supernatant (cytosolic fraction) was passed directly though a 1-ml DEAE cellulose column (DEAE Sephacel ® ; Pharmacia Diagnostics AB, Uppsala, Sweden) equilibrated with ion exchange buffer (25 mM Tris-HCl, pH 7.4, 0.5 mM EDTA, 0.5 mM EGTA, 0.05% Triton X-100, 10 mM ␤ -mercaptoethanol, 1 g/ml leupeptin, and 1 g/ml aprotinin), washed with 15 ml of the same buffer, and eluted with 2.5 ml of 0.2 M NaCl in the same buffer. The effluent was used for kinase assay and protein measurement in the cytosol. The pellet (membrane fraction) was dissolved in 0.5 ml ion exchange buffer. After vortexing and centrifugation (10 min, 13,000 g ), the supernatant was passed though and eluted from a similar DEAE cellulose column. 5 l of eluted material was assayed for kinase activity in a total volume of 25 l, with the following final concentrations: 20 mM Tris-HCl (pH 7.5), 10 mM MgCl 2 , 0.1 mg/ml bovine serum albumin, 0.25 mM EGTA, 0.4 mM CaCl 2 , 0.1 mM ATP, 0.1 M PKC biotinylated peptide substrate neurogranin [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] (AAK-IQASFRGHMARKK), 0.02 Ci/ l ␥ -[ 32 P]ATP (6,000 Ci/mmol), and with or without PKC activators (230 g/ml phosphatidylserine in combination with 23 g/ml diacylglycerol). Mixtures were incubated at 30 Њ C for 20 min, and the reaction was stopped by adding guanidine hydrochloride (final concentration, 2.5 M). 10 l of terminated reaction mixture was spotted onto a SAM 2 ™ membrane (streptavidin matrix) and washed (according to the protocol) to remove free, unincorporated ␥ -[ 32 P]ATP, followed by liquid scintillation counting (Ecoscint™; National Diagnostics, Atlanta, GA) for [ 32 P] incorporation into neurogranin. Basal phosphorylation of neurogranin, in the absence of exogenous phospholipid activators, served as the assay blank for PKC activity. Activation of PKC is estimated by translocation of enzymatic activity from cytosolic to membrane fractions.
Protein kinase A activity was measured with a SAM 2 ™ Protein Kinase A Assay System (Promega Corp.). Cells were treated in 6-cm plates as described for the PKC assay, then harvested with 0.2 ml PBS (pH 7.4), and lysed by freezing and thawing in 100 l cold extraction buffer (25 mM Tris-HCl, pH 7.4, 0.5 mM EDTA, 0.5 mM EGTA, 0.05% Triton X-100, 10 mM ␤ -mercaptoethanol, 1 g/ml leupeptin, and 1 g/ml aprotinin). After centrifugation (10 min, 13,000 g ), the supernatant was used directly for protein kinase assay and protein measurement. 5 l of supernatant was assayed for 5 min at 30 Њ C, in a total volume of 25 l, with (final concentrations) 40 RNA extraction and northern blots. Total RNA was prepared from PC12 cells by extraction in guanidinium thiocyanate (RNAzol II; TelTest, Inc., Friendswood, TX). 20 g of total cellular RNA was fractionated on formaldehyde-agarose gels and transferred to a nylon filter. The integrity of the RNA was judged by the appearance of 28S and 18S rRNA bands on the ethidium bromide-stained gel. Northern blots were done as previously described (26) .
Random primer-labeled (27) cDNA probes were a 1.6-kbp rat chromogranin A cDNA (28) , and a 381-bp mouse cyclophilin cDNA (29) , used as a normalizing probe for a housekeeping (constitutively expressed) mRNA.
Hybridizations and washes were done at 65 Њ C. Between probes, filters were stripped by boiling for 30 min in 0.1 ϫ SSC/0.5% SDS, before rehybridization.
Transcriptional activation (nuclear run-on assay). Nuclear run-on assays, to assess the rate of initiation of new chromogranin A transcripts in PC12 cells after nicotine, PMA, or both, were accomplished as previously described (10) .
Statistics. Results are reported as the mean value Ϯ one SEM. Data were analyzed by either t test (two groups) or ANOVA (three or more groups), using the software packages Statworks or Cricketgraph (Cricket Software, Malvern, PA), or StatView (Abacus Concepts Inc., Berkeley, CA), each for the Macintosh microcomputer. Differences were considered significant if P Ͻ 0.05. Nicotine (60 M) also triggered extracellular 45 Ca 2ϩ net uptake into PC12 cells (to 6,107Ϯ188 dpm/well; P Ͻ 0.02); this stimulated uptake was decreased by 84% (to 960Ϯ1.4 dpm/ well; P Ͻ 0.001) by the nicotinic cholinergic antagonist hexamethonium (10 M), and completely abolished (to Ͻ 0Ϯ177 dpm/well; P Ͻ 0.001) by the l-type calcium channel antagonist nifedipine (10 M). By contrast, membrane depolarization with 55 mM KCl also caused cellular uptake of 45 Ca 2ϩ (to 6,357Ϯ457 dpm/well; P Ͻ 0.02), but such stimulated uptake could be blocked by nifedipine (to 86Ϯ505 dpm/well; P Ͻ 0.02), though not by hexamethonium (to 5,706Ϯ674 dpm/ well).
Results

Effects
Removal of sodium from the extracellular space prevented both catecholamine secretory and chromogranin A transcriptional responses to nicotinic cholinergic stimulation (Table I) , where transcription was evaluated by expression of a transfected 1,133-bp mouse chromogranin A promoter/luciferase reporter plasmid.
Effects of nicotinic cholinergic stimulation and/or PKC activation, alone or combined, on catecholamine secretion and chromogranin A biosynthesis. Both nicotinic cholinergic stimulation (by nicotine, 10
Ϫ3 M) and PKC activation (by PMA, 10 Ϫ7 M) augmented the level of the endogenous chromogranin A mRNA (Fig. 1) .
In a nuclear runoff experiment ( Fig. 2 ) after 1 h of exposure of PC12 cells to either nicotine or PMA, the effects of each agent on chromogranin A gene expression seemed to occur at the level of transcriptional activation (that is, an increase in rate of initiation of new chromogranin A transcripts).
Nicotine or PMA, given separately, each activated catecholamine secretion, as well as a transfected 1,133-bp mouse chromogranin A promoter/luciferase reporter plasmid (Table  II) . cAMP activated chromogranin A transcription, though not catecholamine secretion.
While removal of extracellular sodium from the medium impairs both the catecholamine secretory and the chromogranin A transcriptional responses to nicotine, both of these responses to PMA were preserved (Table I) .
Signal transduction during activation of exocytotic catecholamine secretion by nicotinic cholinergic stimulation: protein kinases and calcium entry.
The dependence of nicotinic-stimulated catecholamine secretion (Table III) on protein kinase classes and calcium entry was somewhat different from the pattern for chromogranin A transcription (Table IV) .
Catecholamine secretion (Table III) in response to nicotine was partially blocked by inhibition of either PKC (with either acute chelerythrine, or chronic PMA pretreatment) or calciumcalmodulin-dependent PKC; combined inhibition of PKC plus calcium-calmodulin-dependent protein kinase virtually abolished nicotinic-stimulated secretion. Blockade of calcium entry through l-type voltage-gated channels also prevented nicotinic-stimulated secretion. Inhibition of other classes of protein kinases (including protein kinase A) had no effect on secretion.
Activation of PKC by acute PMA (10 Ϫ7 M) also stimulated catecholamine secretion, and the effect was selectively blocked by PKC inhibition, though not by inhibition of other protein kinases; in particular, inhibition of calcium-calmodulin-dependent protein kinase did not affect PMA-stimulated secretion. The transfected 1133-bp mouse chromogranin A promoter drives expression of a luciferase reporter. The nicotine stimulation time was 48 h, while the PMA stimulation time was 6 h before cell harvest. Units of promoter activity are as defined in Table I . Preincub., preincubation. *Significantly (P Ͻ 0.05) different from the mock value for that condition (same row). ‡ Significantly (P Ͻ 0.05) different from the control value for nicotine or PMA stimulation (same column). Results are mean valueϮone standard error (n ϭ 4 determinations/condition).
Signal transduction during activation of chromogranin A transcription by nicotinic cholinergic stimulation:protein kinases and calcium entry.
Since nicotinic cholinergic secretory responses in chromaffin cells are associated with influx of calcium through l-type voltage-gated calcium channels (30), we tested the involvement of extracellular calcium influx, as well as several classes of protein kinases, in the chromogranin A transcriptional response to nicotinic stimulation (Table IV) .
Nicotinic stimulation augmented by 3.3-fold (P Ͻ 0.05), reporter expression directed by the transfected chromogranin A promoter in PC12 chromaffin cells. The response was substantially (P Ͻ 0.05) blunted (though not completely abolished) during PKC inhibition, either by the specific inhibitor chelerythrine, or by PKC inactivation by prior chronic PMA. By contrast, inhibitors of protein kinase A, cGMP-dependent protein kinase, or calcium-calmodulin dependent protein kinase did not affect the nicotinic response of the chromogranin A promoter.
Blunting (P Ͻ 0.05, Table IV) of the chromogranin A promoter response to nicotine by nifedipine suggested a requirement for extracellular calcium influx in the transcriptional response. The combination of PKC inhibition plus calcium channel blockade virtually abolished nicotinic activation of the chromogranin A promoter (Table IV) . Sequestration of cytosolic free calcium by EGTA/AM also blunted the transcriptional response of the transfected chromogranin A promoter to nicotine.
Activation of PKC by acute PMA (10 Ϫ7 M) also stimulated the chromogranin A promoter, and the effects of acute PMA were blocked by PKC inhibition by either chelerythrine or chronic PMA pretreatment, though not by blockade of calcium entry by nifedipine.
After nicotinic stimulation, total cellular PKC activity increased by ‫ف‬ 70% (Table V, from 13,218Ϯ675 to 22,477Ϯ987 pmol ATP incorporated into substrate/min, P Ͻ 0.05), and there was a marked shift of PKC activity distribution within the cell, from the cytosol to the membrane fraction (21.1Ϯ 0.96-79.5Ϯ4.78%, Table V, P Ͻ 0.05). Thus, not only was existing PKC activated (translocated to membranes) by exposure of PC12 cells to nicotine, but its biosynthesis was also likely stimulated. By contrast, after nicotine there was no change in either total cellular protein kinase A activity or that fraction activated by endogenous cAMP (Table V) .
Expression of constitutively activated mutants of either ␣-or ␤-isoforms of PKC each activated the chromogranin A promoter (Table VI) , and each synergized activation of the chromogranin A promoter by nicotine.
In a PC12 variant lacking protein kinase A activity (line A126-1B2), both the chromogranin A transcriptional and the catecholamine secretory responses to nicotine were maintained (Table VII) . Transcriptional and secretory effects of agents that selectively influence cytosolic calcium. Since blockade of l-type voltage-gated cell surface calcium channels (by nifedipine) blunted or abolished the effects of nicotinic stimulation on both catecholamine secretion and chromogranin A promoter activity (Tables III and IV) , we examined the effects of several agents that influence entry of calcium into the cytosol from extracellular or intracellular sources.
After cytosolic calcium was chelated by intracellular EGTA, nicotinic stimulation of chromogranin A transcription was substantially blunted.
Agents whose actions affect extracellular calcium entry into the cytosol through cell surface l-type voltage-gated calcium channels (such as nicotine, membrane depolarization with 55 mM KCl, the l-type channel agonist BayK 8644, or the combination of KCl plus BayK 8644) coactivated both catecholamine secretion and chromogranin A transcription (Table   VIII) . Calcium entry through ATP-gated P 2x cell surface calcium channels (31) also activated both secretion and transcription. By contrast, the calcium ionophores A23187 or ionomycin, which allow extracellular calcium entry by creating artificial calcium pores in the cell membrane, triggered catecholamine secretion but not chromogranin A transcription; indeed, chromogranin A transcription fell by ‫ف‬ 50% after the calcium ionophores, even as catecholamine secretion rose markedly (by 2.8-to 12.8-fold).
In the absence of extracellular calcium (Table VIII) , the effects of both nicotine and PMA on catecholamine secretion were abolished; the effects of nicotine on transcription were blunted, while those of PMA were abolished.
There was a general correspondence ( Fig. 3 ; r ϭ 0.897, P ϭ 0.002) between activation of secretion and activation of the chromogranin A promoter by maneuvers that influence calcium entry into the cytosol through l-type calcium channels, although prevention of calcium entry from the extracellular space (by either calcium removal or calcium channel blockade) more effectively inhibited secretion than transcription during nicotinic stimulation.
Agents that modulate calcium release from intracellular stores (Table VIII) had no effect on chromogranin A promoter activity; among these agents, caffeine stimulated catecholamine secretion. Barium, whose complex actions on chro- Response of norepinephrine secretion or transfected chromogranin A promoter activity to agents that influence Ca 2ϩ entry from the extracellular space versus internal depots. The transfected 1133-bp mouse chromogranin A promoter drives expression of a luciferase reporter. Stimulation times were 12 h for KCl, and 48 h for other stimuli to promoter/ reporter expression, and 30 min for secretion. Units of secretion and promoter activity are as defined in Tables II and III maffin cells may involve barium entry through l-type calcium channels and subsequent release of calcium from intracellular stores (32, 33) , triggered secretion, but not chromogranin A transcription.
Were the transcriptional effects of long-term membrane depolarization with 55 mM KCl (see Table XI ) specifically medicated by opening of l-type voltage-gated calcium channels? 100 M verapamil had no effect on basal expression of the transfected mouse chromogranin A promoter/luciferase reporter in PC12 cells, but blocked KCl-induced activation of expression by 79% (data not shown), arguing for such specificity.
Effect of secretagogues on cytosolic calcium concentration in PC12 chromaffin cells. Using PC12 cells loaded with the calcium-fluorescent dye Fura-2 (Table IX) , we studied the effects on cytosolic calcium of those agents (Table VIII) that provoked catecholamine secretion or chromogranin A promoter activation.
The increments of cytosolic calcium after nicotine or membrane depolarization by KCl were substantially blocked by the l-type channel antagonist verapamil, but largely unaffected by the N-type channel antagonist -conotoxin; thus, calcium entry after either nicotine or KCl seemed to involve l-type channels.
The more modest increments in cytosolic calcium after bradykinin, caffeine, or thapsigargin were largely unaffected by the absence (or chelation by EGTA) of extracellular calcium, or by blockade of cell surface l-type or N-type calcium channels; these results are compatible with calcium release from intracellular (endosomal) stores. The effects of barium on cytosolic calcium were blunted by verapamil, consistent with a requirement for entry of barium into the cell through l-type channels (32, 33) ; the lack of effect of extracellular calcium chelation by EGTA indicates that the cytosolic calcium increment after barium was at least partly derived from intracellular stores.
Role of the chromogranin A promoter's proximal CRE box in nicotinic activation. When progressive 5Ј deletions of the mouse chromogranin A promoter (Fig. 4) were exposed to nicotine or phorbol ester, much of the promoter activation by each compound mapped to the region between Ϫ77 bp to Ϫ61 bp upstream of the cap site; this is the region of the promoter's functional (15) cAMP response element (TGACGTAA; Ϫ71 to Ϫ64 bp). There were, however, some differences in response to nicotine or PMA in other promoter regions. Deletion from Ϫ425 bp to Ϫ328 bp, a region that includes a partial consensus match for an AP-1 site ([Ϫ418 bp] 5Ј-TGAGC-GAG-3Ј [Ϫ425 bp], partial [6/8-bp match] homology with an AP1 consensus TGAGTCAG [34] ), diminished the promoter response to nicotine, though not to PMA. A 43-bp promoter retained a minimal response to PMA, though no response to nicotine (in this promoter [13] , the TATA box [here: TATATAAAA] is at position Ϫ25 to Ϫ17 bp).
We then evaluated two site-directed mutants of the chromogranin A promoter's cAMP response element (Table X) , in mouse chromogranin A promoter/reporter plasmids. Both a 6/8-bp change in the cAMP response element (from TGACG-TAA to CATCACCA; changes in bold) and a more subtle 1-bp point-gap mutation (from TGACGTAA to TGA-GTAA) substantially (P Ͻ 0.05) blunted the promoter's responses to both nicotine and PMA.
Is a cAMP response element sufficient to mediate promoter responses to a variety of calcium-dependent stimuli? Several cAMP response element variations were transferred to a neutral, heterologous promoter TK/luciferase reporter PC12 cells in stirred suspension within a cuvette were loaded with Fura-2/AM, washed, resuspended, and recorded in a fluorometer. The peak response of cytosolic calcium concentration to various secretagogues (grouped by effects on Ca 2ϩ entry from extracellular versus intracellular sources) and modulators is listed. The concentration of each secretagogue or modulator is given only at the first listing in the column. Unless otherwise indicated, the extracellular fluid (bath) contained 2 mM CaCl 2 . The average basal calcium concentration was 339 nM. BaCl 2 is administered in the absence of extracellular calcium in the bath.
(parent plasmid, pTK-LUC), then transfected and stimulated with nicotine, KCl, cAMP, or PMA (Table XI) . The chromogranin A cAMP response element (TGACGTAA) as well as a consensus cAMP response element (TGACGTCA) increased their expression in response to all four kinds of stimulation, while a point-gap mutant cAMP response element (TGA-GTAA) responded partially to nicotine, KCl, or PMA, but not to cAMP.
Greenberg et al. (35) identified an 8-bp motif (TGA-CGTTT), at position Ϫ60 bp in the c-fos promoter, which confers a promoter response to cytosolic calcium increments, and which is similar in sequence (6/8 bp match) to a cAMP response element consensus (TGACGTCA); this sequence has been referred to as a calcium response element (36) . When a 71-bp c-fos promoter/CAT reporter plasmid containing this calcium response element at Ϫ60 bp (36) was transfected into PC12 cells, its basal CAT reporter expression (48 h after transfection) of 3,016Ϯ123 cpm/mg protein, was increased (P Ͻ 0.05) to 5,433Ϯ187 cpm/mg protein after nicotinic stimulation (1 mM, 48 h). After 48 h of 0.1 M phorbol myristate acetate, CAT reporter activity was also stimulated (P Ͻ 0.05) to 4,223Ϯ154 cpm/mg protein.
To test the role of the cAMP response element binding protein CREB in relaying the nicotinic signal to the chromogranin A promoter's cAMP response element, we cotransfected a plasmid expressing the CREB dominant negative mutant (i.e., CREB antagonist) KCREB (Table XII) . KCREB expression diminished the chromogranin A promoter's response to cAMP by ‫ف‬ 97%, to nicotine by ‫ف‬ 70%, to KCl by ‫ف‬ 63%, and to PMA by ‫ف‬ 64%.
Discussion
Although much is known about how nicotinic cholinergic stimulation triggers exocytotic corelease of catecholamines and peptides from the chromaffin cell (31, (37) (38) (39) , the mechanisms whereby the cell resynthesizes the secreted peptides are not yet completely understood (10, 40) . For this reason, we analyzed signal transduction during the responses of both catecholamine secretion and chromogranin A promoter activity to Effects of nicotine (1 mM, 48 h) or phorbol ester (PMA, 0.1 M, 6 h) on mouse chromogranin A (CgA) promoter/luciferase reporter plasmids with cAMP response element mutations. Mutant bases in the CRE box are designated in bold type. In the mouse chromogranin A promoter, the functional wild-type CRE box (TGACGTAA) is at position Ϫ71 to Ϫ64 bp upstream of the cap (transcription initiation) site. Data are shown as mean valuesϮSEM (n ϭ 4) for luciferase/protein ratios. *Significantly (P Ͻ 0.05) different from the corresponding wild-type group in the same stimulation condition (same column). ‡ Stimulated group was significantly (P Ͻ 0.05) different from mock in the same plasmid (same row). All (nicotine-or PMA-) stimulated group ratios were significantly (P Ͻ 0.05) higher than the corresponding mock group (same row). CgA, chromogranin A. CRE, cAMP response element. Cap site, transcription initiation site. pXP-100, 100-bp mouse chromogranin A promoter (wild-type) fused to luciferase reporter. pXP-77, 77-bp mouse chromogranin A promoter (wild-type) fused to luciferase reporter. M13, cAMP response element mutant (CATCACCA) of pXP-100. M41, cAMP response element mutant (TGA-GTAA) of pXP-77. physiologic (nicotinic cholinergic) stimulation of chromaffin cells, as well as to stimuli that provoke calcium entry and enzymatic (protein kinase) responses to calcium into such cells.
Initial results on cation fluxes indicated that nicotine triggers both Na ϩ and Ca 2ϩ entry into PC12 cells (Table I) , however, membrane depolarization-stimulated Ca 2ϩ entry could be blocked by inhibition of l-type calcium channels, though not by nicotinic cholinergic antagonism with hexamethonium. Hence, entry of Ca 2ϩ through l-type channels seems to be a step distal to initial Na ϩ entry through the nicotinic cholinergic cation pore, which, in neuronal nicotinic receptors, is generally most permeable to Na ϩ (41). Indeed, removal of Na ϩ from the extracellular space virtually abolished both the catecholamine secretory and the chromogranin A transcriptional responses to nicotinic cholinergic stimulation (Table I) , consistent with the role of the nicotinic cholinergic receptor as an extracellular ligand-gated cation pore permeable principally to sodium (41) , and as the initial point of signal transduction for all processes responding to nicotinic cholinergic stimulation (41) .
We found that nicotinic cholinergic stimulation augmented both catecholamine release and chromogranin A promoter activity in PC12 cells (Tables III and IV) . The protein kinase dependencies of these two responses to nicotinic stimulation were different: chromogranin A transcription was largely mediated by PKC activation, while secretion was, in part, mediated by both PKC and Ca 2ϩ -calmodulin-dependent protein kinase (Tables III and IV) . Activation of endogenous PKC by nicotine was confirmed enzymatically (Table V) : a marked shift in PKC enzymatic activity from the cytosol to the membrane fraction confirmed typical posttranslational activation of the enzyme, while an increase in total cellular PKC activity (cytosolic plus membrane forms; Table V) also suggested an increase in biosynthesis of the enzyme after nicotine. Pharmacologic activation of PKC by acute phorbol ester exposure augmented both secretion and chromogranin A transcription (Tables III and IV) .
Involvement of protein kinases in chromaffin cell catecholamine secretion has been documented previously by Burgoyne and Norman (42, 43) , and Holz and co-workers (44, 45) presented evidence for involvement of both PKC and calciumcalmodulin-dependent protein kinase (10) . Involvement of PKC in the chromogranin A biosynthetic response to nicotinic stimulation in chromaffin cells was suggested by Simon et al. (46) , who found that PKC inhibition (by either sphingosine, or The mouse chromogranin A 1133-bp promoter/luciferase reporter plasmid (pXP-1133) was cotransfected with either the KCREB expression vector (pRSV-KCREB, in which KCREB expression is driven by the strong RSV long terminal repeat), or an irrelevant control plasmid (pBluescript). Transfection amounts were as follows: pXP-1133, 3 g/ml, plus either pRSV-KCREB or pBluescript, each 3 g/ml; there were 0.4 ml/well in 12-well plates. Units are luciferase activity normalized to mg protein of each sample. Stimulation times were 48 h for nicotine or cAMP, 6 h for PMA, and 8 h for KCl. *Treatment group significantly (P Ͻ 0.05) different from mock (unstimulated) group in the same row. ‡ KCREB group significantly (P Ͻ 0.05) different from pBluescript group in the same column. Results are mean valueϮSEM, n ϭ 4 replicates/condition. cAMP, dibutyryl cAMP. phorbol ester pretreatment) inhibited or abolished incorporation of [ 35 S]methionine into newly biosynthesized chromogranin A protein.
Is there a role for cAMP-dependent protein kinase A in the transcriptional response of chromogranin A to nicotinic cholinergic stimulation? Involvement of protein kinase A might be suggested by the involvement of the chromogranin A promoter's CRE box in cis and the transcription factor CREB in trans. The nicotinic transcriptional response mapped onto the chromogranin A promoter's cAMP response element (Tables X-XII; Fig. 4) , and was impaired by selective CRE box mutations (Table X) . Furthermore, dominant negative KCREB mutant studies (Table XII) established a role in trans for the transcription factor CREB in relaying the nicotinic signal to the cAMP response element in cis. Nicotinic stimulation of PC12 cells also phosphorylates CREB on serine 133 (10). Protein kinase A, however, was not activated by nicotine (Table  V) , and the transcriptional response of chromogranin A to nicotine was unimpaired by protein kinase A chemical (KT-5720) inhibition (Table IV) or absence (variant A126-1B2; Table IX) in PC12 cells. By contrast, nicotinic transcriptional activation of chromogranin A was blocked by several types of PKC inhibition (Table IV) , and augmented by PKC overexpression (Table VI). Of note, activation of CREB through phosphorylation at serine 133 by calcium-dependent protein kinases, including PKC, has been established in PC12 cells and other systems (20, 35, (47) (48) (49) . Thus, our data are most consistent with a key role for CREB in nicotinic activation of chromogranin A biosynthesis, but with CREB activation through phosphorylation by PKC.
By contrast, Sabban et al. (4) have established a role for both protein kinase A and the promoter's cAMP response element in the transcriptional response of tyrosine hydroxylase to nicotinic secretory stimulation. In that system (4), a nicotinictriggered influx of calcium into the cytosol may activate an adenylyl cyclase, but here adenylyl cyclase chemical inhibition did not impair the transcriptional response of chromogranin A to nicotine. We did however, uncover a subtle interaction between cAMP and nicotine in activation of chromogranin A transcription: when nicotine and cAMP were combined, their effects on chromogranin A transcription were synergistic (Table II), suggesting that their signal transduction towards chromogranin A transcription is not entirely via independent pathways; indeed, both nicotine and cAMP signal to chromogranin A gene expression through the same cis and trans elements, the cAMP response element (Tables X and XI) and the transcription factor CREB (Table XII) .
Blockade of calcium entry through l-type cell surface calcium channels inhibited nicotinic activation of both secretion and chromogranin A transcription (Tables III and IV) . We therefore examined the secretory and transcriptional effects of a variety of agents that selectively perturb entry of calcium into the cytosol by several routes ( Table VIII ). Agents that influenced calcium entry through l-type voltage-gated calcium channels exerted parallel effects on both secretion and chromogranin A transcription (Fig. 3) , although prevention of calcium entry into the cytosol during nicotinic cholinergic stimulation (by calcium channel blockade or removal of calcium from the extracellular fluid) more effectively prevented secretion than chromogranin A transcription. ATP, which allows extracellular calcium to enter the cytosol through P 2x ligandgated cell surface calcium channels in PC12 cells (31) also triggered both secretion and transcription (Table IX) .
By contrast, agents that allowed calcium entry into the cytosol from artificial cell surface calcium pores (such as the calcium ionophores A23187 or ionomycin), or agents that provoked calcium efflux from intracellular stores (such as caffeine or barium) increased secretion, but did not augment chromogranin A transcription (Table VIII) .
Livett et al. (32, 33) have previously reported a lack of effect of the powerful secretory stimulus barium on chromaffin cell gene expression for the secreted peptide proenkephalin A and the catecholamine biosynthetic enzyme phenylethanolamine-N-methyltransferase. The effects of the secretagogue barium in chromaffin cells are complex and incompletely understood (29, 32, 33, (50) (51) (52) ; barium may gain entry to the cell by the l-type voltage-gated cell surface calcium channel (Table  XI) (50) , and then induce release of calcium from internal stores (Table VIII) (50) . PKC may also mediate barium's actions on secretion (52) .
What is the significance of route of calcium entry into the cytosol (Tables VIII and IX) in triggering transcription? Gallin and Greenberg (53) and Ginty (54) have also noted very different neuronal gene expression responses to extracellular calcium influx through l-type voltage-gated calcium channels versus ligand-gated calcium channels (e.g., NMDA receptors), though they have not investigated the effects of intracellular calcium store release on gene expression. Different routes of calcium entry may also differ in intrinsic permeability to calcium as well as kinetics of calcium flux (55) . Other evidence (56) suggests that an increase in calcium concentration within the nucleus itself is crucial to activation of CREB-mediated gene expression; whether influx of calcium to the cytosol from the extracellular space results in greater increments in nuclear calcium than does influx from intracellular stores is not known.
Nicotinic stimulus transcription coupling in chromaffin cells has also been examined for responsible promoter regions in the catecholamine biosynthetic enzymes tyrosine hydroxylase (3, 4, 57, 58) , dopamine ␤-hydroxylase (59), and phenylethanolamine N-methyltransferase (60) , as well as the secretory peptide proenkephalin A (61) . Such previous studies suggest that two promoter domains may be crucial in nicotinic responses: the cAMP response element (3, 4) and the AP1 site (62) . Likewise, the cAMP response element in the chromogranin A promoter is crucial ( Fig. 4 ; Tables X-XII).
In a previous report (10), we optimized dose-response relationships for nicotine (from 10 Ϫ8 M to 10 Ϫ2 M) on both catecholamine secretion and chromogranin A biosynthesis in PC12 cells. Catecholamine secretion was maximal at 10 Ϫ4 M nicotine, while chromogranin A transcription was maximal at 10 Ϫ3 M nicotine; both responses declined at higher doses of nicotine, suggesting desensitization at the highest agonist dose (63). While a maximal secretory response to 10 Ϫ4 M nicotine is typical for chromaffin cells (64) , the response of a transfected promoter takes place over a much longer time course (48 h versus 30 min), perhaps allowing for further time-dependent desensitization. The dissociation constant (K d ) values for acetylcholine binding to various nicotinic cholinergic receptor species range from 1 to 158 M (41).
The emerging picture of nicotinic stimulus coupling to secretion versus chromogranin A transcription in chromaffin cells, based on these studies, is outlined schematically in Fig. 5 . Nicotinic cholinergic stimulation results initially in entry of sodium from the extracellular space through the nicotinic cation pore (41) , which depolarizes the cell membrane, thereby open-ing cell surface l-type voltage-gated calcium channels. Once in the cytosol, this pool of calcium activates PKC to trigger both the chromogranin A promoter and catecholamine secretion; the same calcium pool also activates calcium-calmodulin-dependent protein kinase, contributing to secretion but not transcription. Agents that result in increments of cytosolic calcium through other routes of entry, such as opening artificial calcium channels with calcium ionophores, or releasing calcium from internal (endosomal) stores, may result in secretion, but no activation of the chromogranin A promoter (Table VIII) .
Thus, the chromogranin A promoter responds (through the crucial intermediary of protein kinase C activation) to receptor-triggered increments in cytosolic calcium entering from the extracellular space. Unlike the response of catecholamine secretion, however, the chromogranin A transcriptional response is highly selective in recognition of the precise route of calcium entry into the cytosol. 
